Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis

Objective: To determine safety, tolerability, and systemic absorption of ingenol mebutate 0.05% gel applied for two consecutive days to treatment areas up to 100cm(2) on the forearm(s) of patients with actinic keratosis. Design and setting: Two studies are reported: a Phase 1, multicenter, open-labe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Aesthet Dermatol
Päätekijät: Anderson, Lawrence, Jarratt, Michael, Schmieder, George, Shumack, Stephen, Katsamas, Janelle, Welburn, Peter
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Matrix Medical Communications 2014
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285446/
https://ncbi.nlm.nih.gov/pubmed/25584134
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia